Cargando…

The effect of spironolactone on diastolic function in haemodialysis patients

Heart failure with preserved ejection fraction (HFpEF) is highly prevalent in patients on maintenance haemodialysis (HD) and lacks effective treatment. We investigated the effect of spironolactone on cardiac structure and function with a specific focus on diastolic function parameters. The MiREnDa t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hauser, T., Dornberger, V., Malzahn, U., Grebe, S. J., Liu, D., Störk, S., Nauck, M., Friedrich, N., Dörr, M., Wanner, C., Krane, V., Hammer, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255262/ https://www.ncbi.nlm.nih.gov/pubmed/33544240 http://dx.doi.org/10.1007/s10554-021-02176-5

Ejemplares similares

Quantification of left ventricular mass by echocardiography compared to cardiac magnet resonance imaging in hemodialysis patients
por: Grebe, Sören Jendrik, et al.
Publicado: (2020)

Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus
por: Hammer, Fabian, et al.
Publicado: (2022)

Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2013)

Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2011)

Effects of spironolactone on extrasystoles and heart rate variability in haemodialysis patients: a randomised crossover trial
por: Eklund, Michael, et al.
Publicado: (2021)

Recurrent cardiovascular events in patients with type 2 diabetes and haemodialysis: analysis from the 4D Study
por: Marx, Nikolaus, et al.
Publicado: (2023)

Comparison of the Effects of Dialysis Methods (Haemodialysis vs Peritoneal Dialysis) on Diastolic Left Ventricular Function Dialysis Methods and Diastolic Function
por: Ellouali, Fedoua, et al.
Publicado: (2016)

Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients
por: CHEN, ZHI-HAO, et al.
Publicado: (2016)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Imatinib and spironolactone suppress hepcidin expression
por: Mleczko-Sanecka, Katarzyna, et al.
Publicado: (2017)

Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2010)

Spironolactone-Induced Unilateral Gynecomastia
por: Veeregowda, Sahana Hadihalli, et al.
Publicado: (2018)

Effect of spironolactone on pain responses in mice
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2010)

Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease
por: Liu, Dan, et al.
Publicado: (2018)

Invasive Validation of Antares, a New Algorithm to Calculate Central Blood Pressure from Oscillometric Upper Arm Pulse Waves
por: Dörr, Marcus, et al.
Publicado: (2019)

Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes
por: Dong, Dan, et al.
Publicado: (2019)

Spironolactone (an adjuvant therapy) in rheumatoid arthritis: a case control study
por: Singh, Harpreet, et al.
Publicado: (2018)

Spironolactone in cardiovascular disease: an expanding universe?
por: Funder, John W.
Publicado: (2017)

Furosemide/spironolactone: Hypotension: case report
Publicado: (2022)

The cardiovascular determinants of physical function in patients with end-stage kidney disease on haemodialysis
por: Adenwalla, Sherna F., et al.
Publicado: (2020)

Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
por: Mackenzie, Isla S., et al.
Publicado: (2016)

Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
por: Minicucci, Marcos F., et al.
Publicado: (2013)

Mild ischemic Injury Leads to Long-Term Alterations in the Kidney: Amelioration by Spironolactone Administration
por: Barrera-Chimal, Jonatan, et al.
Publicado: (2015)

DRESS Syndrome Secondary to Spironolactone with Atypical Presentation
por: Bains, Anupama, et al.
Publicado: (2020)

Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022)

Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology
por: Pereira, Sofia S., et al.
Publicado: (2021)

Effects of Eprosartan on Diastolic Function and Neurohormones in Patients with Hypertension and Diastolic Dysfunction
por: Voors, Adriaan A., et al.
Publicado: (2010)

The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure–HFrEF
por: Naser, Nabil, et al.
Publicado: (2023)

Use, tolerability and compliance of spironolactone in the treatment of heart failure
por: Lachaine, Jean, et al.
Publicado: (2011)

Agranulocytosis Associated With Spironolactone Therapy: A Case Report
por: Fershko, Adam A., et al.
Publicado: (2011)

S47. ADD-ON SPIRONOLACTONE FOR THE TREATMENT OF SCHIZOPHRENIA (SPIRO TREAT)
por: Roeh, Astrid, et al.
Publicado: (2018)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Spironolactone and Cardiac Arrhythmias in Hemodialysis Patients: Helpful or Harmful?
por: Pun, Patrick H.
Publicado: (2023)

Topical Spironolactone in the Treatment of Evaporative Dry Eye Disease
por: Wong, Calvin W, et al.
Publicado: (2023)

CMR for Assessment of Diastolic Function
por: Westenberg, Jos J. M.
Publicado: (2011)

The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study
por: Wu, Vin-Cent, et al.
Publicado: (2017)

Spironolactone-induced XPB degradation requires TFIIH integrity and ubiquitin-selective segregase VCP/p97
por: Chauhan, Anil K., et al.
Publicado: (2020)

The Association between Bone Quality and Atherosclerosis: Results from Two Large Population-Based Studies
por: Lange, V., et al.
Publicado: (2017)

Residual renal function in incremental haemodialysis
por: Vartia, Aarne
Publicado: (2018)

The 50th anniversary of haemodialysis in Krakow, Poland
por: Ostrowski, Janusz, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4pjdjhkhnp33tbehcu7f9t9eiu